Characteristic | Number or mean±SD (range or %) |
Number of patients (male/female) | 146 (116/30) |
Number of observations (male/female) | 891 (731/160) |
Age (years) | 49.0±13.4 (17–76) |
Total body weight (kg) | 66.0±14.8 (29–124) |
Height (cm) | 169.1±8.2 (130–190) |
Serum creatinine (μmol/L) | 78.2±71.7 (25.5–1100) |
Postoperative day | 12.0±11.9 (1–96) |
Haemoglobin (g/L) | 112.0±18.5 (14–168) |
Haematocrit (%) | 34.0±5.3 (11–66) |
Albumin (g/L) | 37.3±5.5 (15–84) |
Total bilirubin (μmol/L) | 16.4±33.2 (25.6–102) |
Unconjugated bilirubin (μmol/L) | 8.9±18.0 (1.4–210.7) |
Alkaline phosphatase (U/L) | 91.0±56.4 (36–413) |
Alanine aminotransferase (U/L) | 35.0±65.7 (6–968) |
Aspartate aminotransferase (U/L) | 23.0±62.2 (9–545) |
γ-Glutamyl transpeptidase (U/L) | 78.0±156.4 (11–1160) |
WuzhiI capsule (+) Prednisone (+) | 53 (36.3%) 146 |
Tacrolimus dose (mg/day) | 8.0±8.5 (0.5–10) |
Drug concentrations (μg/mL) | 11.4±4.7 (1.5–31.8) |
Main comorbidities | |
Infection | 45 (30.8%) |
Graft failure | 30 (20.5%) |
Renal dysfunction | 19 (13.0%) |
Acute rejection | 16 (11.0%) |
Hepatic dysfunction | 8 (5.5%) |